Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Why Don't We Have More Protein-Protein Drug Molecules? | Main | Another Blogroll Update »

December 8, 2009

Pfizer's Pearl River Layoffs

Email This Entry

Posted by Derek

Pfizer's rounds of layoffs after the Wyeth merger are continuing, and look to go on for some time. A reader in New York state sends along word that there's been some controversy over the cuts at the Pearl River site. New York law requires a company to give both the state (and employees) 90 days notice if it lays off more than a set number or percentage of its staff. Pfizer's definitely over both limits, but according to the local newspaper (the Times Herald-Record), employees were told that the law didn't apply to them.

One Pearl River employee, whose identity was confirmed by the Times Herald-Record and who was granted anonymity, said company representatives told the laid-off employees the WARN law didn't apply to them. That source expressed concern that Pfizer was intentionally laying off small pockets of people to skirt WARN.

Now the paper (taking credit for the change) reports that Pfizer has indeed filed with the state that 200 employees will be let go in March. The paper has heard that a total of about 600 people will be laid off, although there are no state papers filed to cover that number yet.

Comments (9) + TrackBacks (0) | Category: Business and Markets | The Dark Side


COMMENTS

1. Former Wyeth on December 8, 2009 10:04 AM writes...

Back in November we were told WARN wouldn't apply, but after review they decided that it would apply in PR and Princeton. WARN letters started going out last month, in some cases by email. It's a very dismal time to be looking for a job right now.

Permalink to Comment

2. Hap on December 8, 2009 6:55 PM writes...

You know, this goes real well with Kindler's push for corporate respect and responsibility. If you want to be trusted that you're not hosing your customers, circumventing the law when it is inconvenient for you and simultaneously screwing your employees (who ought to be less expendable and more valuable to you than your customers) isn't going to help. (I understand that without customers, you have nothing, but a single employee can do a whole lot more damage to your company than a single customer. To paraphrase, you have to be trusted by the people you lie to, after all.)

Permalink to Comment

3. Thomas McEntee on December 8, 2009 9:22 PM writes...

C&EN had a blurb in the most recent issue about Pfizer in China. I think they're talking in terms of having ultimately 550 R&D people in Beijing plus one other Chinese city. That's almost equivalent to the purported eventual loss of 600 positions. BTW, WuXi had one of the two industrial ads in that issue.

Permalink to Comment

4. Chemjobber on December 8, 2009 11:35 PM writes...

That WuXi ad might as well have been written entirely in Chinese; the tagline at the bottom of the ad ("WE ARE DETERMINED TO SERVE YOU BETTER") was kind of odd, too.

Permalink to Comment

5. milkshake on December 8, 2009 11:44 PM writes...

No, they are really that shortsighted - they can get hit by a class-action lawsuit for the unpaid severance, by the ex-employees. It would not be the first time that this has happened to Pfizer.

Permalink to Comment

6. Thomas McEntee on December 9, 2009 7:06 AM writes...

Correction to my comment (#3): C&EN reported in the 30 Nov issue that Pfizer has 350 people in Shanghai and has signed a MOU to build an R&D center in Wuhan that will employ 200.

Permalink to Comment

7. Mr AtoZ on December 9, 2009 9:54 AM writes...

What gets me more than anything is the American consumer.  How on earth can they sit back and buy stuff from countries knowing what's going on over there: whether it's child labor (did you see where the orphans got blown up in a fireworks factory?), huge amounts of pollution (China passed the U.S. in that regard two years ago), no worker safety (thousands of miners die each year), no product safety (milk, pharma, lead paint in toys), etc.  I can't believe people don't look at the country of origin and say enough is enough.

Permalink to Comment

8. marklar on December 9, 2009 9:33 PM writes...

#2 Hap:

Love the reference to Pink Floyd's 'Dogs' in your paraphrase

Permalink to Comment

9. Dr Doom on December 10, 2009 3:46 PM writes...

Actually they're trying this layoff trick all across the globe. At Sandwich each group was treated individually so as to not trigger the 100-person threshold for 90 day consultation. Very dubious legally but who's got the balls in government to tell Pfizer they're breaking the law. There will be a lot more heartbreak in 2011 when Frank resizes the headcount again to match the revenue.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings